Kintor Pharma Announces Completion of First Patient Enrollment in Long-term Safety Phase III Trial of KX-826 for Treatment of AGA : vimarsana.com

Kintor Pharma Announces Completion of First Patient Enrollment in Long-term Safety Phase III Trial of KX-826 for Treatment of AGA

/PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and...

Related Keywords

United States , China , Suzhou , Jiangsu , Peking , Beijing , Kintor Pharma , Jianzhong Zhang , Prnewswire Kintor Pharmaceutical Limited Pharma , Kintor Pharmaceutical , University People Hospital , China National Medical Products Administration , Pharmaceutical Limited , Long Term Safety Trial , Professor Jianzhong Zhang , Peking University People , Long Term Safety ,